HCA Midwest Health Kansas City — Kansas City, Missouri

HCA Midwest Health Kansas City is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

HCA Midwest Health Kansas City has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Non Hodgkin Lymphoma, KRAS p, G12c Mutated /Advanced Metastatic NSCLC.

Sponsors: Rhizen Pharmaceuticals SA, Amgen.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Health Kansas City?

HCA Midwest Health Kansas City has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Health Kansas City conducted?

HCA Midwest Health Kansas City has 2 clinical trials on record, with 1 currently active. Their work covers Non Hodgkin Lymphoma, KRAS p, G12c Mutated /Advanced Metastatic NSCLC.

Is HCA Midwest Health Kansas City accredited by Crixeo Health?

HCA Midwest Health Kansas City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Health Kansas City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.